US Broker Ratings

UroGen Pharma Ltd. (URGN) Stock Analysis: A Biotech with High Growth Potential and an 84% Upside

UroGen Pharma Ltd. (NASDAQ: URGN), a biotechnology firm focused on urothelial and specialty cancers, is currently making waves in the healthcare sector. With a market capitalization..

Exxon Mobil Corporation (XOM) Stock Analysis: Unlocking a 13% Upside Potential for Investors

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, stands as a formidable player in the integrated oil and gas industry. With a commanding..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 70% Potential Upside in the Healthcare Sector

Cytek Biosciences, Inc. (NASDAQ: CTKB) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $426.84..

agilon health, inc. (AGL) Stock Analysis: Navigating a Potential 76.74% Upside in the Healthcare Sector

Investors in the healthcare sector are increasingly turning their attention to agilon health, inc. (NYSE: AGL), a company poised at the intersection of innovative healthcare delivery..

BioLife Solutions (BLFS) Investor Outlook: Analyzing the 50% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS) stands as a pivotal player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Bothell, Washington,..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring the 55.59% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) stands out in the biotechnology sector, particularly in the niche of developing treatments for retinal diseases and other ocular conditions. With..

Wave Life Sciences Ltd. (WVE): Investor Outlook on a High-Potential Biotech Stock with 159% Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is garnering significant attention from investors with its promising drug development platform and substantial potential upside...

Omnicell, Inc. (OMCL): Investor Outlook Reveals 56% Potential Upside

Omnicell, Inc. (NASDAQ: OMCL), a notable player in the healthcare sector, specifically within the health information services industry, presents an intriguing opportunity for investors seeking exposure..

MannKind Corporation (MNKD) Stock Analysis: A Promising Biotech Play with 146.82% Potential Upside

For investors with an eye on the biotechnology sector, MannKind Corporation (NASDAQ: MNKD) presents a compelling opportunity. With a market capitalization of $1.16 billion, MannKind operates..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a Potential 39.62% Upside in the Medical Devices Sector

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specializes in medical devices with a focus on surgical instruments, neurosurgical, and wound..

Opko Health, Inc. (OPK): Investor Outlook and Potential Upside of 185%

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, operates within the diagnostics and research industry. With a market capitalization of $1.11 billion,..

Pacira BioSciences, Inc. (PCRX)

⚠️ No article content returned.

..

Disc Medicine, Inc. (IRON) Stock Analysis: Potential 63.78% Upside Captivates Investor Interest

Disc Medicine, Inc. (NASDAQ: IRON), a promising player in the biotechnology sector, is garnering significant attention from investors, distinguished by its robust market cap of $2.06..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 30.92% Upside Potential Beckons Investors

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector’s medical instruments and supplies industry, presents a compelling case for investors looking for growth..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 56% Potential Upside Amid Healthcare’s Digital Evolution

Evolent Health, Inc. (NYSE: EVH), a prominent player in the health information services industry, is gaining attention from investors with a compelling potential upside of 56.05%...

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 53% Upside Potential in the Thriving Eyecare Market

Harrow, Inc. (NASDAQ: HROW) stands out in the healthcare sector as a dynamic player specializing in ophthalmic pharmaceutical products. With a market capitalization of $1.36 billion,..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a 97% Upside in Biotechnology

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is emerging as a compelling player in the biotechnology sector, capturing investor attention with an impressive potential upside of 97.38% based..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Buy Ratings Signal 77.76% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC) is emerging as a captivating opportunity for investors seeking exposure in the healthcare sector, specifically within the medical devices industry. With..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a 52.9% Potential Upside in the Healthcare Sector

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a notable player in the healthcare sector, specializing in the development, manufacturing, and marketing of generic and proprietary injectable, inhalation,..

Janux Therapeutics (JANX) Stock Analysis: Unveiling a 222% Upside Potential in the Biotech Sector

For investors with a keen eye on the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents a compelling opportunity. This San Diego-based company is making strides..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds